CDK4 and breast carcinoma: Currently, there are several confirmed regimens for improving DFS in patients with breast cancer, including prolonged tamoxifen duration [4], switching to AIs [6], addition of OFS [8] and addition of CDK4/6 inhibitor abemacilib [9].